Alterna Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,509
Closed -$209K 105
2020
Q1
$209K Buy
+1,509
New +$207K 0.3% 57
2019
Q4
Sell
-1,881
Closed -$210K 125
2019
Q3
$210K Buy
+1,881
New +$209K 0.25% 107
2019
Q1
Sell
-9,214
Closed -$758K 236
2018
Q4
$758K Buy
+9,214
New +$1.03M 0.12% 126

Other funds holding LLY

Alterna Wealth Management's LLY Position: Q2 2020 in Review

Alterna Wealth Management sold out of Eli Lilly (LLY) in Q2 2020, closing a stake of 1,509 shares — an estimated $209K sold.

Alterna Wealth Management first reported a position in LLY in Q4 2018 and held it in 3 quarters. The position peaked at $758K in Q4 2018. 1,764 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Alterna Wealth Management reported no remaining Eli Lilly position as of Q2 2020 after selling out during the quarter.
  • Alterna Wealth Management sold 1,509 Eli Lilly shares in Q2 2020, an estimated $209K.
  • Alterna Wealth Management first reported a position in Eli Lilly in Q4 2018 and held it in 3 quarters.
  • Alterna Wealth Management's Eli Lilly position peaked at $758K in Q4 2018.
  • 1,764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Alterna Wealth Management's 13F filing for Q2 2020, filed 27 Jul 2020.